切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2022, Vol. 16 ›› Issue (05) : 347 -350. doi: 10.11817/j.issn.1673-9248.2022.05.011

综述

血管性帕金森综合征的临床特征及诊治研究进展
郑茂凤1, 时晶1, 李婷1, 徐筱青1, 田金洲1,()   
  1. 1. 100700 北京市,北京中医药大学东直门医院脑病三科
  • 收稿日期:2021-11-12 出版日期:2022-10-01
  • 通信作者: 田金洲
  • 基金资助:
    中央高校基本科研业务费专项资金(2019-JYB-TD-007,BZY-JMZY-2022-002)

The clinical characteristics, diagnosis and treatment of vascular Parkinsonism

Maofeng Zheng1, Jing Shi1, Ting Li1, Xiaoqing Xu1, Jinzhou Tian1,()   

  1. 1. Third Department of Brain Disease, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China
  • Received:2021-11-12 Published:2022-10-01
  • Corresponding author: Jinzhou Tian
引用本文:

郑茂凤, 时晶, 李婷, 徐筱青, 田金洲. 血管性帕金森综合征的临床特征及诊治研究进展[J/OL]. 中华脑血管病杂志(电子版), 2022, 16(05): 347-350.

Maofeng Zheng, Jing Shi, Ting Li, Xiaoqing Xu, Jinzhou Tian. The clinical characteristics, diagnosis and treatment of vascular Parkinsonism[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2022, 16(05): 347-350.

血管性帕金森综合征(VP)是一种与脑血管病相关的临床异质性综合征,其临床特征与原发性帕金森病有着明显区别。随着影像技术的发展,目前已有越来越多的研究关注VP的诊断及治疗。本文就近年来VP的发病机制、临床表现、影像学表现、诊断和治疗方面的研究进展进行综述,其中中医药在其治疗方面有其价值所在。

Vascular Parkinsonism (VP) is a heterogeneous clinical syndrome associated with cerebrovascular diseases. Its clinical features are significantly different from primary Parkinson's disease. With the development of imaging technology, more and more studies have focused on the diagnosis and treatment of this clinical entity. In this article, the pathogenesis, clinical manifestations, imaging, diagnosis, and treatment of VP in recent years were reviewed, among which traditional Chinese medicine was of value in the treatment.

1
Critchley M. Arteriosclerotic Parkinsonism [J]. Brain, 1929, 52: 23-83.
2
Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease [J]. Mov Disord, 1987, 2(1): 1-8.
3
Demirkiran M, Bozdemir H, Sarica Y. Vascular Parkinsonism: a distinct, heterogeneous clinical entity [J]. Acta Neurol Scand, 2001, 104(2): 63-67.
4
Caslake R, Taylor K, Scott N, et al. Age and gender specific incidence of vascular Parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: the PINE study [J]. Parkinsonism Relat Disord, 2014, 20(8): 834-839.
5
Levin OS, Chimagomedova AS, Skripkina NA, et al. Nonmotor symptoms in vascular and other secondary Parkinsonism [J]. Int Rev Neurobiol, 2017, 134: 1303-1344.
6
王丽娟, 张玉虎. 中国血管性帕金森综合征诊断与治疗专家共识 [J]. 全科医学临床与教育, 2017, 15(4): 364-367.
7
Vizcarral JA, Lang AE, Sethi KD, et al. Vascular Parkinsonism: deconstructing a syndrome [J]. Mov Disord, 2015, 30(7): 886-894.
8
Mantese CE, Hainzenreder TB. Neuromelanin accumulation in Substantia nigra in vascular Parkinsonism [J]. J Neural Transm (Vienna), 2020, 127(1): 1089-1091.
9
Korczyn AD. Vascular Parkinsonism-characteristics, pathogenesis and treatment [J]. Nat Rev Neurol, 2015, 11(6): 319-326.
10
De Laat KF, Tuladhar AM, van Norden AG, et al. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease [J]. Brain, 2011, 134(Pt 1): 73-83.
11
Salsone M, Caligiuri ME, Vescio V, et al. Microstructural changes of normal-appearing white matter in vascular Parkinsonism [J]. Parkinsonism Relat Disord, 2019, 63: 60-65
12
Dunet V, Deverdun J, Charroud C, et al. Cognitive impairment and basal ganglia functional connectivity in vascular Parkinsonism [J]. AJNR Am J Neuroradiol, 2016, 37(12): 2310-2316
13
FitzGerald PM, Jankovic J. Lower body Parkinsonism: evidence for vascular etiology [J]. Mov Disord, 1989, 4(3): 259-260.
14
Factor SA. The clinical spectrum of freezing of gait in atypical Parkinsonism [J]. Mov Disord, 2008, 23 Suppl 2: S431-S438.
15
Gupta D, Kuruvilla A. Vascular Parkinsonism: what makes it different? [J]. Postgrad Med J, 2011, 87(1034): 829-836.
16
Nonnekes J, Goselink RJM, Růžička E, et al. Neurological disorders of gait, balance and posture: a sign-based approach [J]. Nat Rev Neurol, 2018, 14(3): 183-189.
17
Ferreira F, Gago MF, Bicho E, et al. Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and vascular Parkinsonism [J]. J Biomech, 2019, 92: 98-104.
18
Ba Okud, Kawabata K, Tachibana H, et al. Primitive reflexes distinguish vascular Parkinsonism from Parkinson's disease [J]. Clin Neurol Neurosurg, 2008, 110(6): 562-565.
19
Vale TC, Barbosa MT, Caramelli P, et al. Vascular Parkinsonism and cognitive impairment: literature review, Brazilian studies and case vignettes [J]. Dement Neuropsychol, 2012, 6(3): 137-144.
20
Colosimo C, Morgante L, Antonini A, et al. Non-motor symptoms in atypical and secondary Parkinsonism: the PRIAMO study [J]. J Neurol, 2010, 257(1): 5-14.
21
Vale TC, Caramelli P, Cardoso F. Clinicoradiological comparison between vascular Parkinsonism and Parkinson's disease [J]. J Neurol Neurosurg Psychiatry, 2015, 86(5): 547-553.
22
Glass PG, Lees AJ, Bacellar A, et al. The clinical features of pathologically confirmed vascular Parkinsonism [J]. J Neurol Neurosurg Psychiatry, 2012, 83(10): 1027-1029.
23
Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory function distinguishes vascular Parkinsonism from Parkinson's disease [J]. J Neurol Neurosurg Psychiatry, 2004, 75(12): 1749-1752.
24
Vale TC, Caramelli P, Cardoso F. Clinicoradiological comparison between vascular Parkinsonism and Parkinson's disease [J]. Neurol Neurosurg Psychiatry, 2014, 86(5): 547-553.
25
Contrafatto D, Mostile G, Nicoletti A, et al. [(123)I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular Parkinsonism [J]. Acta Neurol Scand, 2012, 126(1): 12-16.
26
Antonini A, Vitale C, Barone P, et al. The relationship between cerebral vascular disease and Parkinsonism: the VADO study [J]. Parkinsonism Relat Disord, 2012, 18(6): 775-780.
27
Dunet V, Deverdun J, Charroud C, et al. MRI volumetric morphometry in vascular Parkinsonism [J]. J Neurol, 2017, 264(7): 1511-1519.
28
Jang W, Park J, Kim JS, et al. Triple stimulation technique findings in vascular Parkinsonism and Parkinson's disease [J]. Clin Neurophysiol, 2014, 125(9): 1834-1839.
29
Zijlmans JC, Daniel SE, Hughes AJ, et al. Clinicopathological investigation of vascular Parkinsonism,including clinical criteria for diagnosis [J]. Mov Disord, 2004, 19(6): 630-640.
30
Rektor I, Bohnen NI, Korczyn AD, et al. An updated diagnostic approach to subtype definition of vascular Parkinsonism-Recommendations from an expert working group [J]. Parkinsonism Related Disord, 2018, 49: 9-16.
31
Ling MJ, Aggarwal A, Morris JG. Dopa-responsive Parkinsonism secondary to right temporal lobe haemorrhage [J]. Mov Disord, 2002, 17(2): 402-404.
32
胡娟娟. 依达拉奉联合多巴丝肼片治疗血管性帕金森综合征的临床效果 [J]. 中国民康医学, 2019, 31(8): 26-27.
33
王琳琳. 丁苯酞联合美多芭治疗血管性帕金森综合征的临床效果观察 [J]. 中国现代药物应用, 2020, 14(1): 186-187.
34
翁国媚, 莫俊宁, 李又佳, 等. 单唾液酸四己糖神经节苷脂钠联合丁苯酞治疗血管性帕金森综合征患者的疗效及对认知功能的影响 [J]. 内科, 2020, 15(2): 195-196, 213.
35
Sato Y, Iwamoto J, Honda Y, et al. Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson' sdisease [J]. Ther Clin Risk Manag, 2013, 9: 171-176.
36
余虹. 强化功能训练对血管性帕金森综合征运动功能的影响 [J]. 中国医学工程, 2019, 27(9): 47-50.
37
夏毅, 康冰, 杨宁, 等. 电针治疗血管性帕金森综合征22例 [J]. 中医杂志, 2011, 52(12): 1056-1057.
38
季庆玲, 周韦玮, 张向芝. 补肾活血熄风方治疗血管性帕金森综合征的临床效果分析 [J].中西医结合心血管病电子杂志, 2020, 8(9): 169.
39
许婉莹, 周世玲, 王麒颖. 熟地通络汤联合针刺对血管性帕金森综合征患者脑血流、认知功能、脑电功能的影响 [J]. 环球中医药, 2020, 13(11): 1890-1893.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[7] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[8] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[9] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
阅读次数
全文


摘要